Bristol Myers Squibb is committed to helping appropriate patients get access to our
medications by providing access and reimbursement support services.

This information is intended for U.S. healthcare professionals and/or healthcare professionals involved in healthcare reimbursement.

Billing and
Diagnosis Codes

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

Reimbursement and Coding Guide for ONUREG
Download

Filter by keyword Clear Filter
Type a keyword to find a specific NDC or ICD-10 code
National Drug Codes (NDC)1 Issued by the FDA

Note:Payers require the submission of the 11-digit NDC on healthcare claim forms. Please use the 11-digit codes shown here.

59572-730-14

COPY

200-mg tablets; Bottle of 14 tablets with 2 desiccant canisters

59572-0730-14

COPY

200-mg tablets; Bottle of 14 tablets with 2 desiccant canisters

59572-740-14

COPY

300-mg tablets; Bottle of 14 tablets with 2 desiccant canisters

59572-0740-14

COPY

300-mg tablets; Bottle of 14 tablets with 2 desiccant canisters

International Classification of Diseases, Tenth Revision, Clinical Modification Diagnosis Codes (ICD-10-CM)2
C92

COPY

Myeloid leukemia

C92.0

COPY

Acute myeloblastic leukemia

C92.00

COPY

Acute myeloblastic leukemia, not having achieved remission

C92.01

COPY

Acute myeloblastic leukemia, in remission

C92.5

COPY

Acute myelomonocytic leukemia

C92.50

COPY

Acute myelomonocytic leukemia, not having achieved remission

C92.51

COPY

Acute myelomonocytic leukemia, in remission

C92.6

COPY

Acute myeloid leukemia with 11q23-abnormality

C92.60

COPY

Acute myeloid leukemia with 11q23-abnormality, not having achieved remission

C92.61

COPY

Acute myeloid leukemia with 11q23-abnormality, in remission

C92.A

COPY

Acute myeloid leukemia with multilineage dysplasia

C92.A0

COPY

Acute myeloid leukemia with multilineage dysplasia, not having achieved remission

C92.A1

COPY

Acute myeloid leukemia with multilineage dysplasia, in remission

C92.Z

COPY

Other myeloid leukemia

C92.Z0

COPY

Other myeloid leukemia, not having achieved remission

C92.Z1

COPY

Other myeloid leukemia, in remission

C92.9

COPY

Myeloid leukemia, unspecified

C92.90

COPY

Myeloid leukemia, unspecified, not having achieved remission

C92.91

COPY

Myeloid leukemia, unspecified, in remission

C93

COPY

Monocytic leukemia

C93.0

COPY

Acute monoblastic/monocytic leukemia

C93.00

COPY

Acute monoblastic/monocytic leukemia, not having achieved remission

C93.01

COPY

Acute monoblastic/monocytic leukemia, in remission

C94

COPY

Other leukemias of specified cell type

C94.0

COPY

Acute erythroid leukemia

C94.00

COPY

Acute erythroid leukemia, not having achieved remission

C94.01

COPY

Acute erythroid leukemia, in remission

C94.2

COPY

Acute megakaryoblastic leukemia

C94.20

COPY

Acute megakaryoblastic leukemia, not having achieved remission

C94.21

COPY

Acute megakaryoblastic leukemia, in remission

The following distributors are authorized to sell ONUREG and are able to service qualified accounts.

Physician Offices

Specialty Distributor Phone Orders Website
Cardinal 1-877-453-3972
Monday-Friday,
7 AM-6 PM CT
(24-hour emergency on call)
https://specialtyonline.cardinalhealth.com
McKesson 1-800-482-6700
Monday-Friday,
7 AM-7 PM CT
https://mscs.mckesson.com
Oncology Supply 1-800-633-7555
Monday-Friday,
8 AM-7 PM CT
https://www.oncologysupply.com

Hospitals and Specialty Pharmacies

Specialty Distributor Phone Orders Fax Orders and Website
ASD Healthcare 1-800-746-6273
Monday-Thursday,
7:30 AM-6:30 PM CT;
Friday, 7 AM-6 PM CT (24-hour emergency on call)
1-800-547-9413
https://www.asdhealthcare.com
Cardinal Health Specialty Pharmaceutical Distribution 1-866-677-4844
Monday-Friday,
7 AM-6 PM CT
(24-hour emergency on call)
1-614-553-6301
https://orderexpress.cardinalhealth.com
McKesson Plasma and Biologics 1-877-625-2566
Monday-Friday,
8 AM-6:30 PM CT
1-888-752-7626
https://connect.mckesson.com

ONUREG® is available through external specialty pharmacies. Please check with your patient’s insurance plan for the appropriate specialty pharmacy.

ONUREG® can also be procured by the practice directly from one of the authorized distributors in the list above. Please ensure your practice has the durable medical equipment (DME) license in place to bill the appropriate DME Medicare Administrative Contractor (DME MAC).

Please see U.S. Full Prescribing Information for ONUREG.

FDA Approval Letter as Posted by the FDA:

ONUREG for the continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy - Approved on 09/01/2020
View Letter

Please see U.S. Full Prescribing Information for ONUREG.

*Healthcare providers should code healthcare claims based upon the service that is rendered, the patient’s medical record, the coding requirements of each health insurer, and best coding practices. Coding guidance provided under this heading does not provide a guarantee of reimbursement and should be considered together with all applicable coding guidance and standards. All of the coding information presented by this website is applicable to outpatient procedures only.

This is a category code and is invalid for stand-alone use. Please use the expanded code listed below.

Please see U.S. Full Prescribing Information for ONUREG.

References:

  1. ONUREG (azacitidine) tablets [package insert]. Princeton, NJ: Bristol-Myers Squibb Company.
  2. Centers for Medicare & Medicaid Services. ICD-10-CM tabular list of diseases and injuries. Accessed June 26, 2020. https://www.cms.gov/Medicare/Coding/ICD10/2020-ICD-10-CM

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

Support Center icon
Support Center: 1-800-861-0048
am to 8 pm ET, Mon - Fri
Schedule a Call icon
Schedule a call from a Care CoordinatorSchedule a Call >
Request a Visit icon
Request a visit from a BMS Access & Reimbursement ManagerRequest a Visit >
Schedule a Call Request a Visit
BMS Logo

©2020 Bristol-Myers Squibb Company. All rights reserved. Access Support is a registered trademark of Bristol-Myers Squibb Company.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Statement. The coding, coverage, and payment information contained within this website is current as of 10/20.

MMUS2002621-01-01 10/20